A Review of the Types of Chemotherapy Drugs Used to Induce Premature Ovarian Failure in Mice

  • Negar Pouladvand Department of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
  • Mahnaz Azarnia Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
  • Hadis Zeinali Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
  • Rouhollah Fathi Department of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
  • Somayeh Tavana Department of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
Keywords: Premature Ovarian Failure, Chemotherapy drugs, Infertility, Mouse.

Abstract

Introduction: The most common complication of chemotherapy is infertility due to premature ovarian failure (POF). POF is defined as the loss of normal ovarian function before age 40, characterized by increased gonadotropin levels, decreased estradiol levels, and diminished ovarian reserve, often leading to infertility. Despite the high impact of POF on general health and quality of life, the pathophysiology of this disease is unclear. For this purpose, animal models provide us with the opportunity to hypothetically investigate the pathogenesis of the disease comprehensively. The most common method of creating an animal model of premature ovarian failure is the use of chemotherapy drugs. In this study, the types of chemotherapy drugs and the relevant molecular pathways that play a role in creating the premature ovarian failure model in mice will be investigated

Conclusion: According to the studies, cyclophosphamide drug is introduced as the most common gonadotoxic drug in order to induce POF model in mice.

Published
2024-08-28
Section
Articles